U.S. Markets closed

[$$] Aralez in Stalking Horse Deals With Nuvo, Deerfield

Aralez Pharmaceuticals Inc. on Wednesday said it signed “stalking horse” agreements to sell its main operating businesses in a pair of deals valued at $240 million. Aralez said health-care investment firm Deerfield Management Co., its secured lender, agreed to buy its Toprol-XL franchise in a deal valued at $130 million. Deerfield also provided a commitment to finance the Nuvo transaction.